Completeness: 57 (82.61%)
Cited: 1 (0.83%)
All atributes instances: 57 (6.98%)
Identification (url, isbn, doi, issn, jstor, pmc, pmid, arxiv, oclc, website): 2 (66.67%)
Filled attributes and number of instances
title
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.
1
date
Mar 1, 2012
1
last1
Verstovsek
1
first1
S
1
last2
Mesa
1
first2
RA
1
last3
Gotlib
1
first3
J
1
last4
Levy
1
first4
RS
1
last5
Gupta
1
first5
V
1
last6
DiPersio
1
first6
JF
1
last7
Catalano
1
first7
JV
1
last8
Deininger
1
first8
M
1
last9
Miller
1
first9
C
1
pages
799–807
1
journal
The New England Journal of Medicine
1
volume
366
1
issue
9
1
doi
10.1056/NEJMoa1110557
1
last20
Erickson-Viitanen
1
last21
Koumenis
1
last22
Sun
1
last23
Sandor
1
last24
Kantarjian
1
first23
V
1
first22
W
1
first21
IL
1
first20
S
1
first24
HM
1
pmid
22375971
1
last15
Hexner
1
last14
Arcasoy
1
last17
Paquette
1
last16
Lyons
1
last11
Talpaz
1
last10
Silver
1
last13
Harvey JH
1
last12
Winton
1
last19
Vaddi
1
last18
Raza
1
first19
K
1
first18
A
1
first12
EF
1
first13
Jr
1
first10
RT
1
first11
M
1
first16
RM
1
first17
R
1
first14
MO
1
first15
E
1
displayauthors
3
1
Points based on comparison of each characteristics of the source with a median of each relevant characteristics of the TOP1000 corresponding sources In English Wikipedia:
| Characteristics | Median* |
|---|---|
| Completeness | 69 |
| Cited | 121 |
| All atributes instances | 817 |
* - as of August 2016
